<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01150474</url>
  </required_header>
  <id_info>
    <org_study_id>09-008045</org_study_id>
    <nct_id>NCT01150474</nct_id>
  </id_info>
  <brief_title>Postoperative Belladonna and Morphine Suppositories in Vaginal Surgery</brief_title>
  <official_title>Randomized Clinical Trial of Postoperative Belladonna and Morphine Suppositories in Vaginal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kristina A. Butler</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our primary aim is to determine whether the routine use of belladonna and morphine
      suppositories will improve pain control following vaginal surgery. Treatment will begin
      immediately following surgery and every 8 hours for 16 hours.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Minimizing postoperative pain is vital to a successful surgical recovery. Inadequate pain
      control may result in nausea, vomiting, an extended hospital stay, and reduced patient
      satisfaction. Oral and parenteral narcotics are commonly used for pain relief and their use
      may exacerbate the incidence of sedation, nausea, and vomiting; ultimately delaying
      convalescence. Previous studies have demonstrated that rectal analgesia following surgery
      results in lower pain scores and less intravenous morphine consumption. Belladonna and opium
      suppositories are routinely prescribed at our institution and their efficacy has not been
      confirmed.

      A prospective, randomized, double-blind, placebo-controlled trial will be undertaken using
      belladonna and opium rectal suppositories following vaginal surgery. Treatment will begin
      immediately following surgery and continue every 8 hours for a total of 3 doses.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain at Hour 4</measure>
    <time_frame>4 hours following surgery</time_frame>
    <description>Pain at 4 hours was recorded using a linear analog pain scale, with 0 being &quot;no pain,&quot; and 10 being &quot;worst pain imaginable.&quot;</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain at Hour 12</measure>
    <time_frame>12 hours after surgery.</time_frame>
    <description>Pain at 12 hours was recorded using a linear analog pain scale, with 0 being &quot;no pain,&quot; and 10 being &quot;worst pain imaginable.&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain at Hour 20</measure>
    <time_frame>20 hours after surgery.</time_frame>
    <description>Pain at 20 hours was recorded using a linear analog pain scale, with 0 being &quot;no pain,&quot; and 10 being &quot;worst pain imaginable.&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Narcotic Rescue Medication</measure>
    <time_frame>For 24 hours following surgery</time_frame>
    <description>Use of all ancillary narcotic medications was taken from the medical record.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Subjects With Nausea</measure>
    <time_frame>Approximately 12 hours after surgery</time_frame>
    <description>This information was taken from the medical record.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Subjects With Vomiting</measure>
    <time_frame>Within 20 hours of surgery</time_frame>
    <description>This information was taken from the medical record.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Times Antiemetic Rescue Medication Was Used</measure>
    <time_frame>First 24 hours after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Subjects Who Used Antiemetic Rescue Medications</measure>
    <time_frame>First 24 hours after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction With Pain Relief</measure>
    <time_frame>Approximately 24 hours following surgery</time_frame>
    <description>Patient satisfaction with pain relief was evaluated 24 hours after surgery using a linear analog satisfaction scale, with 0 being &quot;very dissatisfied,&quot; and 10 being &quot;very satisfied.&quot;</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">103</enrollment>
  <condition>Vaginal Surgery</condition>
  <arm_group>
    <arm_group_label>Belladonna and Opium Suppositories</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Belladonna (16.2 mg) and opium (60 mg) suppositories administered rectally immediately following surgery and every 8 hours for 16 hours for a total of 3 doses.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Suppositories</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo suppositories administered rectally immediately following surgery and every 8 hours for 16 hours for a total of 3 doses.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Belladonna and Opium Suppositories</intervention_name>
    <description>Belladonna (16.2 mg) and opium (60 mg) suppositories administered rectally immediately following surgery and every 8 hours for 16 hours for a total of 3 doses.</description>
    <arm_group_label>Belladonna and Opium Suppositories</arm_group_label>
    <other_name>B &amp; O Supprettes</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo Suppositories</intervention_name>
    <description>Placebo suppositories administered rectally immediately following surgery and every 8 hours for 16 hours for a total of 3 doses.</description>
    <arm_group_label>Placebo Suppositories</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Scheduled for elective vaginal surgery requiring general anesthesia at the Mayo Clinic
             Hospital. This would include a vaginal hysterectomy with culdoplasty or
             post-hysterectomy prolapse repair, including culdoplasty with or without
             anterior/posterior repair.

        Exclusion Criteria:

          -  Participation in another trial using an investigational product.

          -  Pregnancy.

          -  Scheduled for a non-vaginal surgical procedure.

          -  Scheduled for a robotic hysterectomy.

          -  Scheduled to have combined surgeries (vaginal surgery plus another non-vaginal
             surgery).

          -  There is a known hypersensitivity to belladonna and/or opium.

          -  Contraindication to narcotic use.

          -  Chronic pain with preoperative pain score greater than 4 out of 10 points.

          -  Clinically significant substance abuse.

          -  Mental condition that may impair the ability to provide study assessments.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kristina Butler, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85054</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 23, 2010</study_first_submitted>
  <study_first_submitted_qc>June 23, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 25, 2010</study_first_posted>
  <results_first_submitted>December 23, 2014</results_first_submitted>
  <results_first_submitted_qc>December 23, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">January 7, 2015</results_first_posted>
  <last_update_submitted>December 23, 2014</last_update_submitted>
  <last_update_submitted_qc>December 23, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 7, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Kristina A. Butler</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <keyword>Belladonna</keyword>
  <keyword>Morphine</keyword>
  <keyword>Suppositories</keyword>
  <keyword>Vaginal</keyword>
  <keyword>Surgery</keyword>
  <keyword>Postoperative</keyword>
  <keyword>Pain</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Opium</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Subjects were recruited at the Mayo Clinic in Arizona, United States from January 2011 to April 2013.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Belladonna and Opium Suppositories</title>
          <description>Belladonna (16.2 mg) and opium (60 mg) suppositories administered rectally immediately following surgery and every 8 hours for 16 hours for a total of 3 doses.</description>
        </group>
        <group group_id="P2">
          <title>Placebo Suppositories</title>
          <description>Placebo suppositories administered rectally immediately following surgery and every 8 hours for 16 hours for a total of 3 doses.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="51"/>
                <participants group_id="P2" count="52"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="41"/>
                <participants group_id="P2" count="49"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Cancer found</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Multiple Studies</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Rectotomy</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Drug did not arrive in time</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Drug not administered</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Surgery Changed</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Belladonna and Opium Suppositories</title>
          <description>Belladonna (16.2 mg) and opium (60 mg) suppositories administered rectally immediately following surgery and every 8 hours for 16 hours for a total of 3 doses.</description>
        </group>
        <group group_id="B2">
          <title>Placebo Suppositories</title>
          <description>Placebo suppositories administered rectally immediately following surgery and every 8 hours for 16 hours for a total of 3 doses.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="41"/>
            <count group_id="B2" value="49"/>
            <count group_id="B3" value="90"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56" spread="12"/>
                    <measurement group_id="B2" value="55" spread="13"/>
                    <measurement group_id="B3" value="55" spread="12.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="41"/>
                    <measurement group_id="B2" value="49"/>
                    <measurement group_id="B3" value="90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="41"/>
                    <measurement group_id="B2" value="49"/>
                    <measurement group_id="B3" value="90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Pelvic Organ Prolapse</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Prolapse</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No Prolapse</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Procedure time</title>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="98" spread="37"/>
                    <measurement group_id="B2" value="96" spread="38"/>
                    <measurement group_id="B3" value="97" spread="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Estimated Blood Loss</title>
          <units>mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="180" spread="250"/>
                    <measurement group_id="B2" value="150" spread="110"/>
                    <measurement group_id="B3" value="161" spread="186"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Preoperative Pain</title>
          <description>Pain was recorded on a validated numeric pain scale (1-10), with 0 = no pain and 10 = worst pain imaginable. Not all participants completed the pain scale, therefore the populations analyzed were Belladonna and Morphine Suppository Arm (N=39), Placebo Suppository Arm (N=45).</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.44" spread="1.25"/>
                    <measurement group_id="B2" value="0.24" spread="0.91"/>
                    <measurement group_id="B3" value="0.3" spread="1.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Pain at Hour 4</title>
        <description>Pain at 4 hours was recorded using a linear analog pain scale, with 0 being &quot;no pain,&quot; and 10 being &quot;worst pain imaginable.&quot;</description>
        <time_frame>4 hours following surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Belladonna and Opium Suppositories</title>
            <description>Belladonna (16.2 mg) and opium (60 mg) suppositories administered rectally immediately following surgery and every 8 hours for 16 hours for a total of 3 doses.</description>
          </group>
          <group group_id="O2">
            <title>Placebo Suppositories</title>
            <description>Placebo suppositories administered rectally immediately following surgery and every 8 hours for 16 hours for a total of 3 doses.</description>
          </group>
        </group_list>
        <measure>
          <title>Pain at Hour 4</title>
          <description>Pain at 4 hours was recorded using a linear analog pain scale, with 0 being &quot;no pain,&quot; and 10 being &quot;worst pain imaginable.&quot;</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.2" spread="2.4"/>
                    <measurement group_id="O2" value="4.1" spread="2.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.82</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain at Hour 12</title>
        <description>Pain at 12 hours was recorded using a linear analog pain scale, with 0 being &quot;no pain,&quot; and 10 being &quot;worst pain imaginable.&quot;</description>
        <time_frame>12 hours after surgery.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Belladonna and Opium Suppositories</title>
            <description>Belladonna (16.2 mg) and opium (60 mg) suppositories administered rectally immediately following surgery and every 8 hours for 16 hours for a total of 3 doses.</description>
          </group>
          <group group_id="O2">
            <title>Placebo Suppositories</title>
            <description>Placebo suppositories administered rectally immediately following surgery and every 8 hours for 16 hours for a total of 3 doses.</description>
          </group>
        </group_list>
        <measure>
          <title>Pain at Hour 12</title>
          <description>Pain at 12 hours was recorded using a linear analog pain scale, with 0 being &quot;no pain,&quot; and 10 being &quot;worst pain imaginable.&quot;</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.4" spread="2.4"/>
                    <measurement group_id="O2" value="3.3" spread="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.75</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain at Hour 20</title>
        <description>Pain at 20 hours was recorded using a linear analog pain scale, with 0 being &quot;no pain,&quot; and 10 being &quot;worst pain imaginable.&quot;</description>
        <time_frame>20 hours after surgery.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Belladonna and Opium Suppositories</title>
            <description>Belladonna (16.2 mg) and opium (60 mg) suppositories administered rectally immediately following surgery and every 8 hours for 16 hours for a total of 3 doses.</description>
          </group>
          <group group_id="O2">
            <title>Placebo Suppositories</title>
            <description>Placebo suppositories administered rectally immediately following surgery and every 8 hours for 16 hours for a total of 3 doses.</description>
          </group>
        </group_list>
        <measure>
          <title>Pain at Hour 20</title>
          <description>Pain at 20 hours was recorded using a linear analog pain scale, with 0 being &quot;no pain,&quot; and 10 being &quot;worst pain imaginable.&quot;</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.5" spread="1.9"/>
                    <measurement group_id="O2" value="3.4" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.07</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Narcotic Rescue Medication</title>
        <description>Use of all ancillary narcotic medications was taken from the medical record.</description>
        <time_frame>For 24 hours following surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Belladonna and Opium Suppositories</title>
            <description>Belladonna (16.2 mg) and opium (60 mg) suppositories administered rectally immediately following surgery and every 8 hours for 16 hours for a total of 3 doses.</description>
          </group>
          <group group_id="O2">
            <title>Placebo Suppositories</title>
            <description>Placebo suppositories administered rectally immediately following surgery and every 8 hours for 16 hours for a total of 3 doses.</description>
          </group>
        </group_list>
        <measure>
          <title>Narcotic Rescue Medication</title>
          <description>Use of all ancillary narcotic medications was taken from the medical record.</description>
          <units>mg IV morphine equivalents</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57" spread="38"/>
                    <measurement group_id="O2" value="66" spread="61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.43</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Subjects With Nausea</title>
        <description>This information was taken from the medical record.</description>
        <time_frame>Approximately 12 hours after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Belladonna and Opium Suppositories</title>
            <description>Belladonna (16.2 mg) and opium (60 mg) suppositories administered rectally immediately following surgery and every 8 hours for 16 hours for a total of 3 doses.</description>
          </group>
          <group group_id="O2">
            <title>Placebo Suppositories</title>
            <description>Placebo suppositories administered rectally immediately following surgery and every 8 hours for 16 hours for a total of 3 doses.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects With Nausea</title>
          <description>This information was taken from the medical record.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.30</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Subjects With Vomiting</title>
        <description>This information was taken from the medical record.</description>
        <time_frame>Within 20 hours of surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Belladonna and Opium Suppositories</title>
            <description>Belladonna (16.2 mg) and opium (60 mg) suppositories administered rectally immediately following surgery and every 8 hours for 16 hours for a total of 3 doses.</description>
          </group>
          <group group_id="O2">
            <title>Placebo Suppositories</title>
            <description>Placebo suppositories administered rectally immediately following surgery and every 8 hours for 16 hours for a total of 3 doses.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects With Vomiting</title>
          <description>This information was taken from the medical record.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.14</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Times Antiemetic Rescue Medication Was Used</title>
        <time_frame>First 24 hours after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Belladonna and Opium Suppositories</title>
            <description>Belladonna (16.2 mg) and opium (60 mg) suppositories administered rectally immediately following surgery and every 8 hours for 16 hours for a total of 3 doses.</description>
          </group>
          <group group_id="O2">
            <title>Placebo Suppositories</title>
            <description>Placebo suppositories administered rectally immediately following surgery and every 8 hours for 16 hours for a total of 3 doses.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Times Antiemetic Rescue Medication Was Used</title>
          <units>number of times antiemetics used</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.7" spread="1.6"/>
                    <measurement group_id="O2" value="1.6" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.83</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Subjects Who Used Antiemetic Rescue Medications</title>
        <time_frame>First 24 hours after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Belladonna and Opium Suppositories</title>
            <description>Belladonna (16.2 mg) and opium (60 mg) suppositories administered rectally immediately following surgery and every 8 hours for 16 hours for a total of 3 doses.</description>
          </group>
          <group group_id="O2">
            <title>Placebo Suppositories</title>
            <description>Placebo suppositories administered rectally immediately following surgery and every 8 hours for 16 hours for a total of 3 doses.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects Who Used Antiemetic Rescue Medications</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30"/>
                    <measurement group_id="O2" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.55</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Satisfaction With Pain Relief</title>
        <description>Patient satisfaction with pain relief was evaluated 24 hours after surgery using a linear analog satisfaction scale, with 0 being &quot;very dissatisfied,&quot; and 10 being &quot;very satisfied.&quot;</description>
        <time_frame>Approximately 24 hours following surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Belladonna and Opium Suppositories</title>
            <description>Belladonna (16.2 mg) and opium (60 mg) suppositories administered rectally immediately following surgery and every 8 hours for 16 hours for a total of 3 doses.</description>
          </group>
          <group group_id="O2">
            <title>Placebo Suppositories</title>
            <description>Placebo suppositories administered rectally immediately following surgery and every 8 hours for 16 hours for a total of 3 doses.</description>
          </group>
        </group_list>
        <measure>
          <title>Satisfaction With Pain Relief</title>
          <description>Patient satisfaction with pain relief was evaluated 24 hours after surgery using a linear analog satisfaction scale, with 0 being &quot;very dissatisfied,&quot; and 10 being &quot;very satisfied.&quot;</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.2" spread="2.5"/>
                    <measurement group_id="O2" value="7.9" spread="2.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.59</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Subjects will be followed for 24 hours after surgery, and the research coordinator will assess for adverse events one week after surgery via the electronic medical record.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Belladonna and Opium Suppositories</title>
          <description>Belladonna (16.2 mg) and opium (60 mg) suppositories administered rectally immediately following surgery and every 8 hours for 16 hours for a total of 3 doses.</description>
        </group>
        <group group_id="E2">
          <title>Placebo Suppositories</title>
          <description>Placebo suppositories administered rectally immediately following surgery and every 8 hours for 16 hours for a total of 3 doses.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal Sepsis</sub_title>
                <description>Within 24 hours of surgery</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="24" subjects_at_risk="41"/>
                <counts group_id="E2" subjects_affected="27" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anemia Postoperative</sub_title>
                <description>Within 24 hours of surgery</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Procedural Hypertension</sub_title>
                <description>Within 24 hours of surgery</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Sinus Tachycardia</sub_title>
                <description>Within 24 hours of surgery</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Procedural Hypotension</sub_title>
                <description>Within 24 hours of surgery</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Postoperative Ileus</sub_title>
                <description>Within 24 hours of surgery</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <description>Within 7 days of surgery</description>
                <counts group_id="E1" events="20" subjects_affected="20" subjects_at_risk="35"/>
                <counts group_id="E2" events="27" subjects_affected="27" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Urinary Retention</sub_title>
                <description>Within 24 hours of surgery</description>
                <counts group_id="E1" events="21" subjects_affected="21" subjects_at_risk="41"/>
                <counts group_id="E2" events="23" subjects_affected="23" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Urinary Tract Infection</sub_title>
                <description>Within 24 hours of surgery</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Sleep Apnea Syndrome</sub_title>
                <description>Within 24 hours of surgery</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Pruritis Generalized</sub_title>
                <description>Within 24 hours of surgery</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Kristina A. Butler</name_or_title>
      <organization>Mayo Clinic</organization>
      <phone>480-301-5934</phone>
      <email>butler.kristina@mayo.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

